Methylphenidate
- Generic Name
- Methylphenidate
- Brand Names
- Adhansia, Aptensio, Biphentin, Concerta, Cotempla, Daytrana, Foquest, Jornay, Metadate, Methylin, Quillichew, Quillivant, Relexxii, Ritalin
- Drug Type
- Small Molecule
- Chemical Formula
- C14H19NO2
- CAS Number
- 113-45-1
- Unique Ingredient Identifier
- 207ZZ9QZ49
- Background
Methylphenidate is a central nervous system stimulant used most commonly in the treatment of Attention-Deficit/Hyperactivity Disorder (ADHD) and for narcolepsy. Also known as the marketed products Ritalin, Concerta, or Biphentin, methylphenidate is used with other treatment modalities (psychological, educational, cognitive behaviour therapy, etc) to improve ...
- Indication
Methylphenidate is indicated for the treatment of Attention Deficit Hyperactivity Disorder (ADHD) in patients 6 years of age and older and for the treatment of narcolepsy.
- Associated Conditions
- Attention Deficit Hyperactivity Disorder (ADHD), Narcolepsy
- Associated Therapies
- -
Bariatric Surgery and Pharmacokinetics of Methylphenidate
- Conditions
- First Posted Date
- 2018-02-22
- Last Posted Date
- 2024-11-14
- Lead Sponsor
- Norwegian University of Science and Technology
- Target Recruit Count
- 1
- Registration Number
- NCT03440190
- Locations
- 🇳🇴
St. Olavs University Hospital, Trondheim, Norway
Methylphenidate and Cognitive Training in Elderly
- Conditions
- Interventions
- First Posted Date
- 2017-09-12
- Last Posted Date
- 2022-08-17
- Lead Sponsor
- University Hospital, Lille
- Target Recruit Count
- 120
- Registration Number
- NCT03280251
- Locations
- 🇫🇷
Hôpital Roger Salengro, CHU, Lille, France
MethylphenIdate for Fatigue in Haematological Cancer
- First Posted Date
- 2017-07-14
- Last Posted Date
- 2018-12-05
- Lead Sponsor
- Henrik Frederiksen
- Target Recruit Count
- 150
- Registration Number
- NCT03218254
- Locations
- 🇩🇰
Odense University Hospital, Odense, Danmark, Denmark
Treatment of Fatigue With Methylphenidate, Modafinil and Amantadine in Multiple Sclerosis
- Conditions
- Interventions
- First Posted Date
- 2017-06-14
- Last Posted Date
- 2020-10-20
- Lead Sponsor
- Johns Hopkins University
- Target Recruit Count
- 141
- Registration Number
- NCT03185065
- Locations
- 🇺🇸
University of California San Francisco, San Francisco, California, United States
🇺🇸Johns Hopkins University, Baltimore, Maryland, United States
TAME-PD - Physical Therapy, Atomoxetine and, Methylphenidate, to Enhance Gait and Balance in Parkinson's Disease
- Conditions
- Interventions
- First Posted Date
- 2016-08-25
- Last Posted Date
- 2024-02-16
- Lead Sponsor
- Hubert Fernandez
- Target Recruit Count
- 42
- Registration Number
- NCT02879136
- Locations
- 🇺🇸
Cleveland Clinic, Cleveland, Ohio, United States
Eye Tracking as a Predictor of Methylphenidate Response in Autism With ADHD
- Conditions
- Interventions
- First Posted Date
- 2016-08-22
- Last Posted Date
- 2021-01-15
- Lead Sponsor
- Children's Hospital Medical Center, Cincinnati
- Target Recruit Count
- 40
- Registration Number
- NCT02874690
- Locations
- 🇺🇸
Cincinnati Children's Hospital Medical Center, Cincinnati, Ohio, United States
Novel Cross-Species Neurophysiological Assays of Reward and Cognitive Domains
- First Posted Date
- 2016-08-04
- Last Posted Date
- 2024-10-30
- Lead Sponsor
- Mclean Hospital
- Target Recruit Count
- 222
- Registration Number
- NCT02855229
- Locations
- 🇺🇸
McLean Hospital, Belmont, Massachusetts, United States
Sensitivity of Project: EVO Monitor Cognitive Measurements to Pharmacological Agents
- Conditions
- Interventions
- First Posted Date
- 2016-07-06
- Last Posted Date
- 2016-11-06
- Lead Sponsor
- Akili Interactive Labs, Inc.
- Target Recruit Count
- 18
- Registration Number
- NCT02822937
- Locations
- 🇺🇸
Clinical Trials of Texas, San Antonio, Texas, United States
Early Interventions in Children With Attention Deficit/Hyperactivity Disorder
- First Posted Date
- 2016-06-21
- Last Posted Date
- 2020-08-18
- Lead Sponsor
- University of Sao Paulo
- Target Recruit Count
- 153
- Registration Number
- NCT02807870
- Locations
- 🇧🇷
Instituto de Psiquiatria do Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo, Sao Paulo, Brazil
Cognitive-Motor Rehabilitation, Stimulant Drugs, and Active Control in the Treatment of ADHD
- Conditions
- Interventions
- First Posted Date
- 2016-05-23
- Last Posted Date
- 2021-02-03
- Lead Sponsor
- Allameh Tabatabai University
- Target Recruit Count
- 48
- Registration Number
- NCT02780102
- Locations
- 🇮🇷
Counseling and guidence Center of the Department of education of region 9 of Tehran, Tehran, Iran, Islamic Republic of
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.